Search

everythinglearnresearchcommunity

for

Search:↓

Guselkumab significantly improves quality of life for people with moderate to severe psoriasis.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Inhibiting plant sterols reduces grapevine pathogen reproduction.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

taVNS reduces vitiligo symptoms in mice.

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Removing anthrax toxin receptor 1 in pigs prevents Senecavirus A infection and causes a rare disease similar to GAPO syndrome.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

miR-182 may help treat hallux valgus by targeting FGF9.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

A man had two rare autoimmune diseases that might be connected.

Blocking certain brain processes reduces mating behavior in female rats.

Certain plant compounds can help prevent and treat a virus in pigs.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Targeting Hedgehog signaling may help treat ligamentum flavum fibrosis.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

Upadacitinib effectively treats pyoderma gangrenosum.

JAK inhibitors show promise in treating difficult skin diseases.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.